Evidence map›Paper›PMID 22945807›Full record

ArticleImmunologic research2013

TLR7 drives accumulation of ABCs and autoantibody production in autoimmune-prone mice.

Anatoly V Rubtsov, Kira Rubtsova, John W Kappler, Philippa Marrack

Open access · greenAbstract read
In one paragraph

Article in Immunologic research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 93 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. The multilayered identity of B cell memory.Cellular & molecular immunology · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. IL-4 alters TLR7-induced B cell developmental program in lupus.Clinical immunology (Orlando, Fla.) · 2025
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Tlr7 drives sex- and tissue-dependent effects in Sjögren's disease.Frontiers in cell and developmental biology · 2024
    Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Anatoly V RubtsovIntegrated Department of Immunology, Howard Hughes Medical Institute, University of Colorado School of Medicine, Denver, CO 80206, USA. rubtsova@njhealth.org
Kira Rubtsova
John W Kappler
Philippa Marrack
Howard Hughes Medical Institute · USNational Jewish Health · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · US

Funding

THE REGULATION OF V ALPHA 7 EXPRESSING T CELLSP01AI022295 · NIAID · NATIONAL JEWISH HEALTH · PI REFAELI, YOSEF · 1985 to 2011
$11.7M
MHC peptide tetramers in type 1 diabetesU19AI046374 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLERS, VERNON MICHAEL · 1999 to 2007
$9.6M
CHARACTERISTICS OF T CELL RECEPTORSR01AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1985 to 2022
$7.3M
Molecular Mechanisms of Immune ToleranceT32AI074491 · NIAID · NATIONAL JEWISH HEALTH · PI CAMBIER, JOHN C, PELANDA, ROBERTA · 2009 to 2023
$4.1M
Control of Chemokine Production by Memory T CellsR01AI052225 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 2002 to 2006
$1.3M
CHARACTERISTICS OF T-CELL RECEPTORSR37AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1992 to 2001
$522k
Characteristics of T Cell ReceptorsR56AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 2012 to 2012
$410k
Howard Hughes Medical InstituteNIAID NIH HHS AI-046374NIAID NIH HHS AI-18785NIAID NIH HHS AI-22295NIAID NIH HHS AI-52225NIAID NIH HHS P01 AI022295NIAID NIH HHS R01 AI018785NIAID NIH HHS R01 AI052225NIAID NIH HHS R37 AI018785NIAID NIH HHS R56 AI018785NIAID NIH HHS U19 AI046374
6 · The paper itself

Abstract

Although autoantibodies are the hallmarks of most autoimmune diseases, the mechanisms by which autoreactive B cells are generated and accumulate are still poorly understood. Overexpression of Toll-like receptor 7 (TLR7) that recognizes single-stranded RNAs has been implicated in systemic lupus erythematosus (SLE), although the cellular mechanism by which this receptor drives the disease is unknown. We recently identified a population of CD11c(+) age-associated B cells (ABCs) which is driven by TLR7 signaling, secretes autoantibodies and appears in autoimmune-prone mice by the time of onset of autoimmunity. Mice lacking the Mer receptor develop autoantibodies and splenomegaly similar to other mouse models of SLE. Here, we show that Mer(-/-) mice that lack TLR7 fail to develop anti-chromatin IgG antibodies, perhaps because they also fail to develop ABCs. Moreover, depletion of CD11c(+) ABCs from Mer(-/-) mice leads to rapid reduction in autoantibodies. Together, these data strongly suggest that ABCs and/or their descendants are the primary source of autoantibodies in Mer(-/-) mice and that TLR7 signaling is crucial for accumulation of ABCs and development of autoantibodies. These data demonstrate for the first time that TLR7, and not TLR9, is responsible for generation of anti-chromatin IgG antibodies in Mer(-/-) mice.

Indexed as

AnimalsAntigens, Differentiation, B-LymphocyteAutoantibodiesB-LymphocytesCD11c AntigenDiphtheria ToxinFemaleGreen Fluorescent ProteinsHeparin-binding EGF-like Growth FactorImmunoglobulin GIntercellular Signaling Peptides and ProteinsMaleMembrane GlycoproteinsMiceMice, TransgenicReceptors, ImmunologicAntigens, Differentiation, B-LymphocyteAutoantibodiesCD11c AntigenDiphtheria ToxinGreen Fluorescent ProteinsHbegf protein, mouseHeparin-binding EGF-like Growth FactorImmunoglobulin GIntercellular Signaling Peptides and ProteinsMembrane Glycoproteinsmouse erythrocyte receptorReceptors, ImmunologicT-bet Transcription FactorT-Box Domain ProteinsTlr7 protein, mouseToll-Like Receptor 7

Identifiers

PMID22945807
PMCPMC3935605
OpenAlexW2003607179

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.